114 related articles for article (PubMed ID: 7495979)
21. Oncogenic pathways in hereditary and sporadic breast cancer.
Kenemans P; Verstraeten RA; Verheijen RH
Maturitas; 2004 Sep; 49(1):34-43. PubMed ID: 15351094
[TBL] [Abstract][Full Text] [Related]
22. Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene.
Jäger D; Stockert E; Scanlan MJ; Güre AO; Jäger E; Knuth A; Old LJ; Chen YT
Cancer Res; 1999 Dec; 59(24):6197-204. PubMed ID: 10626813
[TBL] [Abstract][Full Text] [Related]
23. Rad52 gene mutations in breast/ovarian cancer families and sporadic ovarian carcinoma patients.
Tong D; Volm T; Eberhardt E; Krainer M; Leodolter S; Kreienberg R; Zeillinger R
Oncol Rep; 2003; 10(5):1551-3. PubMed ID: 12883740
[TBL] [Abstract][Full Text] [Related]
24. Genetic analysis of eight breast-ovarian cancer families with suspected BRCA1 mutations.
Couch FJ; Garber J; Kiousis S; Calzone K; Hauser ER; Merajver SD; Frank TS; Boehnke M; Chamberlain JS; Collins FS
J Natl Cancer Inst Monogr; 1995; (17):9-14. PubMed ID: 8573462
[TBL] [Abstract][Full Text] [Related]
25. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.
Merajver SD; Frank TS; Xu J; Pham TM; Calzone KA; Bennett-Baker P; Chamberlain J; Boyd J; Garber JE; Collins FS
Clin Cancer Res; 1995 May; 1(5):539-44. PubMed ID: 9816013
[TBL] [Abstract][Full Text] [Related]
26. Somatic mutations in the BRCA1 gene in sporadic ovarian tumours.
Merajver SD; Pham TM; Caduff RF; Chen M; Poy EL; Cooney KA; Weber BL; Collins FS; Johnston C; Frank TS
Nat Genet; 1995 Apr; 9(4):439-43. PubMed ID: 7795652
[TBL] [Abstract][Full Text] [Related]
27. Identification of germline BRCA1 and BRCA2 genetic alterations in Greek breast cancer moderate-risk and low-risk individuals--correlation with clinicopathological data.
Kataki A; Gomatos I; Pararas N; Armakolas A; Panousopoulos D; Karantzikos G; Voros D; Zografos G; Markopoulos C; Leandros E; Konstadoulakis M
Clin Genet; 2005 Apr; 67(4):322-9. PubMed ID: 15733268
[TBL] [Abstract][Full Text] [Related]
28. Risk models for familial ovarian and breast cancer.
Antoniou AC; Gayther SA; Stratton JF; Ponder BA; Easton DF
Genet Epidemiol; 2000 Feb; 18(2):173-90. PubMed ID: 10642429
[TBL] [Abstract][Full Text] [Related]
29. Mutation analysis of the THRA1 gene in breast cancer: deletion/fusion of the gene to a novel sequence on 17q in the BT474 cell line.
Futreal PA; Cochran C; Marks JR; Iglehart JD; Zimmerman W; Barrett JC; Wiseman RW
Cancer Res; 1994 Apr; 54(7):1791-4. PubMed ID: 7511052
[TBL] [Abstract][Full Text] [Related]
30. Risk assessment and presymptomatic molecular diagnosis in hereditary breast cancer.
Merajver SD; Petty EM
Clin Lab Med; 1996 Mar; 16(1):139-67. PubMed ID: 8867588
[TBL] [Abstract][Full Text] [Related]
31. Evolution of the tumor suppressor BRCA1 locus in primates: implications for cancer predisposition.
Pavlicek A; Noskov VN; Kouprina N; Barrett JC; Jurka J; Larionov V
Hum Mol Genet; 2004 Nov; 13(22):2737-51. PubMed ID: 15385441
[TBL] [Abstract][Full Text] [Related]
32. [Somatic genetics of breast cancer].
Bièche I; Lidereau R
Bull Cancer; 1997 Jan; 84(1):83-96. PubMed ID: 9180865
[TBL] [Abstract][Full Text] [Related]
33. [Tumor suppressor gen mutation in the germ line: its significance in familial and sporadic tumors].
Müller H; Scott RJ
Schweiz Med Wochenschr; 1995 Jul; 125(30):1445-54. PubMed ID: 7676234
[TBL] [Abstract][Full Text] [Related]
34. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
35. Germline alterations in the CLSPN gene in breast cancer families.
Erkko H; Pylkäs K; Karppinen SM; Winqvist R
Cancer Lett; 2008 Mar; 261(1):93-7. PubMed ID: 18077083
[TBL] [Abstract][Full Text] [Related]
36. [Inherited breast and ovarian cancers].
Gerdes AM; Ejlertsen B
Ugeskr Laeger; 2006 Jun; 168(24):2367-9. PubMed ID: 16822422
[TBL] [Abstract][Full Text] [Related]
37. Are PALB2 mutations associated with increased risk of male breast cancer?
Sauty de Chalon A; Teo Z; Park DJ; Odefrey FA; ; Hopper JL; Southey MC
Breast Cancer Res Treat; 2010 May; 121(1):253-5. PubMed ID: 20091115
[No Abstract] [Full Text] [Related]
38. Implications of genomic instability in the diagnosis and treatment of breast cancer.
Wiechec E
Expert Rev Mol Diagn; 2011 May; 11(4):445-53. PubMed ID: 21545260
[TBL] [Abstract][Full Text] [Related]
39. Long-range transcriptional regulation of breast cancer genes.
Betts JA; French JD; Brown MA; Edwards SL
Genes Chromosomes Cancer; 2013 Feb; 52(2):113-25. PubMed ID: 23077082
[TBL] [Abstract][Full Text] [Related]
40. How cancer gene testing can benefit patients.
Murphy P; Bray W
Mol Med Today; 1997 Apr; 3(4):147-52. PubMed ID: 9134527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
